BYONDIS B V has a total of 28 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2015. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are BIOSTAPRO AB, INTERVACC AB and SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 11 | |
#2 | United States | 7 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | Canada | 1 | |
#5 | Hungary | 1 | |
#6 | Taiwan | 1 | |
#7 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks | |
#5 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Enzymes | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Separation |
# | Name | Total Patents |
---|---|---|
#1 | Coumans Rudy Gerardus Elisabeth | 11 |
#2 | Verheijden Gijsbertus Franciscus Maria | 6 |
#3 | Spijker Henri Johannes | 4 |
#4 | Rouwendal Gerard | 3 |
#5 | Matlung Hanke Lottie | 3 |
#6 | Arends Roland Jan | 3 |
#7 | Voortman Gerrit | 3 |
#8 | Koper Norbert Peter | 3 |
#9 | Ariaans Gerardus Joseph Andreas | 3 |
#10 | Franke Katarina | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020099653A1 | HUMANIZED ANTI-SIRPα ANTIBODIES | |
AU2018371966A1 | Improved process for the synthesis of linker-drug vc-seco-DUBA | |
US2020010408A1 | Process for the preparation of mono-protected α,ω-diamino alkanes | |
AU2017218615A1 | Selective reduction of cysteine-engineered antibodies | |
AU2015205588A1 | Duocarmycin ADCs for use in treatment of endometrial cancer |